Emotional disorders and cognitive dysfunctions are key focus areas in psychiatric treatment, with various biological mechanisms explored through methods like fear conditioning and rat models.
Research showed that both fear-conditioned and methamphetamine-induced reverse tolerance rats exhibit increased dopamine release in the amygdala, which may relate to abnormal emotional processing in cognitive disorders like schizophrenia.
Antipsychotic medications, such as haloperidol and clozapine, can help regulate this excessive dopamine release, suggesting their role in stabilizing emotional context processing and improving the connection between emotion and cognition.